Download PDF
Thromb Haemost 2000; 84(05): 747-751
DOI: 10.1055/s-0037-1614109
Review Article
Schattauer GmbH

Phenotyping the Clotting System

H. Coenraad Hemker
1   From Synapse b. v. and the Department of Biochemistry, Cardiovascular Research Institute (CARIM) Maastricht, The Netherlands
,
Suzette Béguin
1   From Synapse b. v. and the Department of Biochemistry, Cardiovascular Research Institute (CARIM) Maastricht, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 26 April 2000

Accepted after revision 31 May 2000

Publication Date:
13 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Agnelli G. Thrombin plays a pivotal role in vascular re-occlusion after PTCA and coronary thrombolysis. Cardiovasc Res 1996; 31: 232-4.
    CrossrefPubMedGoogle Scholar
  • 2 Badimon L, Meyer BJ, Badimon JJ. Thrombin in arterial thrombosis. Haemostasis 1994; 24: 69-80.
    PubMedGoogle Scholar
  • 3 Chesebro JH, Rauch U, Fuster V, Badimon JJ. Pathogenesis of thrombosis in coronary artery disease. Haemostasis 1997; 27: 12-8.
    PubMedGoogle Scholar
  • 4 Fuster VVM. Thrombosis in Cardiovascular Disorders. Philadelphia: W. B. Saunders; 1992
    Google Scholar
  • 5 A double-blind trial to assess long-term oral anticoagulant therapy in elderly patients after myocardial infarction. Report of the Sixty Plus Reinfarction Study Research Group. Lancet 1980; 02: 989-94.
    PubMedGoogle Scholar
  • 6 Neri GGSerneri, Rovelli F, Gensini GF, Pirelli S, Carnovali M, Fortini A. Effectiveness of low-dose heparin in prevention of myocardial reinfarction. Lancet 1987; 01: 937-42.
    PubMedGoogle Scholar
  • 7 Kumar R, Béguin S, Hemker HC. The influence of fibrinogen and fibrin on thrombin generation – evidence for feedback activation of the clotting system by clot bound thrombin. Thromb Haemost 1994; 72: 713-21.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Roy AB. Catastrophes and bifurcations in biochemical networks. In: Catastrophe, Theory and Applications. Sinha DK. ed. New York: John Wiley & sons; 1981: 112-9.
    Google Scholar
  • 9 Selkov EE. Non linearity of multienzyme systems. In: Analysis and simulation of Biochemical Systems. Hemker HC, Hess B. eds. Amsterdam, North Holland: American Elsevier; 1972: 145-62.
    Google Scholar
  • 10 Butenas S, van’t Veer C, Mann KG. “Normal” thrombin generation. Blood 1999; 94: 2169-78.
    PubMedGoogle Scholar
  • 11 Mann KG. How much factor V is enough?. Thromb Haemost 2000; 83: 3-4.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Seegers WH. A personal perspective on hemostasis and thrombosis (1937-1981). Semin Thromb Hemost 1981; 07: 177-307.
    PubMedGoogle Scholar
  • 13 Biggs R, Macfarlane RG. Human Blood Coagulation and its Disorders. Oxford: Blackwell; 1953
    Google Scholar
  • 14 Hartert HSJA. The physical and biological constants of thrombelastography. Biorheology 1962; 01: 31-9.
    CrossrefPubMedGoogle Scholar
  • 15 Béguin S, Lindhout T, Hemker HC. The effect of trace amounts of tissue factor on thrombin generation in platelet rich plasma, its inhibition by heparin. Thromb Haemost 1989; 61: 25-9.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Pieters J, Lindhout T, Hemker HC. In situ-generated thrombin is the only enzyme that effectively activates factor VIII and factor V in thromboplastin-activated plasma. Blood 1989; 74: 1021-4.
    PubMedGoogle Scholar
  • 17 Josso F, Prou-Wartelle O. Interaction of tissue factor and factor VII at the earliest phase of coagulation. Thromb Diath Haemorr. 1965. Suppl. 17: 35-44.
    Google Scholar
  • 18 Osterud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 1977; 74: 5260-4.
    CrossrefPubMedGoogle Scholar
  • 19 Von dem Borne PA, Bajzar L, Meijers JC, Nesheim ME, Bouma BN. Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis. J Clin Invest 1997; 99: 2323-7.
    CrossrefPubMedGoogle Scholar
  • 20 Cawthern KM, van’t Veer C, Lock JB, DiLorenzo ME, Branda RF, Mann KG. Blood coagulation in hemophilia A and hemophilia C. Blood 1998; 91: 4581-92.
    PubMedGoogle Scholar
  • 21 Rapaport SI, Rao LV. The tissue factor pathway: how it has become a prima ballerina. Thromb Haemost 1995; 74: 7-17.
    PubMedGoogle Scholar
  • 22 Bevers EM, Comfurius P, van Rijn JL, Hemker HC, Zwaal RF. Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem 1982; 122: 429-36.
    CrossrefPubMedGoogle Scholar
  • 23 Rijkers DT, Wielders SJ, Tesser GI, Hemker HC. Design and synthesis of thrombin substrates with modified kinetic parameters. Thromb Res 1995; 79: 491-9.
    CrossrefPubMedGoogle Scholar
  • 24 Hemker HC, Wielders S, Kessels H, Béguin S. Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential. Thromb Haemost 1993; 70: 617-24.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 25 Wielders S, Mukherjee M, Michiels J, Rijkers DT, Cambus JP, Knebel RW, Kakkar V, Hemker HC, Béguin S. The routine determination of the endogenous thrombin potential, first results in different forms of hyper- and hypocoagulability. Thromb Haemost 1997; 77: 629-36.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 Hemker HC, Giesen PLA, Ramjee M, Wagenvoord R, Béguin S. The thrombogram: monitoring thrombin generation in platelet rich plasma. Thromb Haemost 2000; 83: 589-91.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 27 Reverter JC, Béguin S, Kessels H, Kumar R, Hemker HC, Coller BS. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and “clinical restenosis”. J Clin Invest 1996; 98: 863-74.
    CrossrefPubMedGoogle Scholar
  • 28 Duchemin J, Pittet JL, Tartary M, Béguin S, Gaussem P, Alhenc-Gelas M, Aiach M. A new assay based on thrombin generation inhibition to detect both protein C and protein S deficiencies in plasma. Thromb Haemost 1994; 71: 331-8.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 29 Rosing J, Tans G, Nicolaes GA, Thomassen MC, van Oerle R, van der Ploeg PM, Heijnen P, Hamulyak K, Hemker HC. Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives. Br J Haematol 1997; 97: 233-8.
    CrossrefPubMedGoogle Scholar
  • 30 Rosing J, Middeldorp S, Curvers J, Christella M, Thomassen LG, Nicolaes GA, Meijers JC, Bouma BN, Buller HR, Prins MH, Tans G. Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study. Lancet 1999; 354: 2036-40.
    CrossrefPubMedGoogle Scholar
  • 31 Béguin S, Lindhout T, Hemker HC. The mode of action of heparin in plasma. Thromb Haemost 1988; 60: 457-62.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 32 Hemker HC. The mode of action of heparin in plasma. In: Thromb Haemost 1987. Verstraete MVJ, Lijnen R, Arnout J. ed. Leuven: Leuven University Press; 1987: 17-36.
    Google Scholar
  • 33 Xi M, Béguin S, Hemker HC. The relative importance of the factors II, VII, IX and X for the prothrombinase activity in plasma of orally anticoagulated patients. Thromb Haemost 1989; 62: 788-91.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 34 Kyrle PA, Mannhalter C, Béguin S, Stumpflen A, Hirschl M, Weltermann A, Stain M, Brenner B, Speiser W, Pabinger I, Lechner K, Eichinger S. Clinical studies and thrombin generation in patients homozygous or heterozygous for the G20210A mutation in the prothrombin gene. Arterioscler Thromb Vasc Biol 1998; 18: 1287-91.
    CrossrefPubMedGoogle Scholar
  • 35 Rotteveel RC, Roozendaal KJ, Eijsman L, Hemker HC. The influence of oral contraceptives on the time-integral of thrombin generation (thrombin potential). Thromb Haemost 1993; 70: 959-62.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 36 Vandenbroucke JP, Helmerhorst FM, Bloemenkamp KW, Rosendaal FR. Third-generation oral contraceptive and deep venous thrombosis: from epidemiologic controversy to new insight in coagulation. Am J Obstet Gynecol 1997; 177: 887-91.
    CrossrefPubMedGoogle Scholar
  • 37 Azar AJ, Cannegieter SC, Deckers JW, Briët E, van Bergen PF, Jonker JJ, Rosendaal FR. Optimal intensity of oral anticoagulant therapy after myocardial infarction. J Am Coll Cardiol 1996; 27: 1349-55.
    CrossrefPubMedGoogle Scholar
  • 38 Bendetowicz AV, Kai H, Knebel R, Caplain H, Hemker HC, Lindhout T, Béguin S. The effect of subcutaneous injection of unfractionated and low molecular weight heparin on thrombin generation in platelet rich plasma – a study in human volunteers. Thromb Haemost 1994; 72: 705-12.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 39 Keularts IMLW, Zivellin A, Seligsohn U, Hemker HC, Béguin S. The role of factor XI in thrombin generation induced by low concentrations of tissue factor. Thromb Haemost. 2000 submitted.
    PubMedGoogle Scholar
  • 40 Béguin S, Kumar R, Keularts I, Seligsohn U, Coller BS, Hemker HC. Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor. Blood 1999; 93: 564-70.
    PubMedGoogle Scholar
  • 41 Herault JP, Dol F, Gaich C, Bernat A, Herbert JM. Effect of clopidogrel on thrombin generation in platelet-rich plasma in the rat. Thromb Haemost 1999; 81: 957-60.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 42 Kessels H, Béguin S, Andree H, Hemker HC. Measurement of thrombin generation in whole blood – the effect of heparin and aspirin. Thromb Haemost 1994; 72: 78-83.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 43 Peyrou V, Lormeau JC, Herault JP, Gaich C, Pfliegger AM, Herbert JM. Contribution of erythrocytes to thrombin generation in whole blood. Thromb Haemost 1999; 81: 400-6.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 44 Ramjee MK. The Use of Fluorogenic Substrates to Monitor Thrombin Generation for the Analysis of Plasma and Whole Blood Coagulation. Anal Biochem 2000; 277: 11-8.
    CrossrefPubMedGoogle Scholar
  • 45 Bos GM, Rijkers DT, Willems HP, den Heijer M, Béguin S, Gerrits WB, Hemker HC. The elevated risk for venous thrombosis in persons with hyperhomocysteinemia is not reflected by the endogenous thrombin potential. Thromb Haemost 1999; 81: 467-8.
    Article in Thieme ConnectPubMedGoogle Scholar